Pierluigi Navarra

10PUBLICATIONS
20CO-AUTHORS
Proteins and peptidesAccounting theory and standardsHaematological tumoursPredictive and prognostic markersMetal organic frameworks
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 17, 2026
CGRP, VIP and PACAP plasmatic levels in migraine patients before and after anti-CGRP(R) monoclonal antibodies treatment.

|Apr 15, 2026
Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis.

Gian Marco Raspolini, Bruno Federico, Mario Cesare Nurchis

|Jan 31, 2026
Main factors associated with variability in the assessment of the objective response rate. A re-analysis of the PHEREXA phase 3 clinical trial.

Gennaro Daniele, Tommaso Giovagnoli, Pierluigi Navarra

|Nov 27, 2020
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Phase 2 Oncology Trials.

Cinzia Dello Russo, Natalia Cappoli, Daniela Pilunni

|May 12, 2017
Optimal Solubility of Diclofenac β-Cyclodextrin in Combination with Local Anaesthetics for Mesotherapy Applications.

Giuseppe Tringali, Pierluigi Navarra

|Apr 12, 2017
Interactions between integrase inhibitors and human arginase 1.

Lucia Lisi, Michela Pizzoferrato, Fabiola Teresa Miscioscia

Pageof 2

Frequent Collaborators

2 joint publications

Cinzia Dello Russo

1 joint publications

Raffaella Cocciolo

1 joint publications

Paola Turella

1 joint publications

Luca Buzzonetti